Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADD-IT: Tolvaptan in acute heart failure
NCT02646540Phase 1Completed
- Sponsor
- Emory University
- Start
- Jan 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tolvaptan in heart failure (HF) (3 arms), sponsored by Emory University. Primary endpoint: Length of Hospitalization Measured in Days. Started Jan 2016; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02646540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646540.